Skip to content

SG&A at other companies

Cabot Corporation logo
Cabot CorporationCBT
$67M+4.7%
Belden logo
BeldenBDC
$138.65M+5.4%
MYR Group logo
MYR GroupMYRG
$69.42M+11.0%
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
$66.38M-26.0%
ADT logo
ADTADT
$364.77M-1.0%
Helen Of Troy logo
Helen Of TroyHELE
$181.44M+4.0%

Other financials

Income statement

See full
Revenue$55.8M+0.6%
Gross profit$17.1M+15.9%
Operating income$5.8M+59.8%
Net income$4.4M+67.3%
EPS (diluted)$0.32+68.4%

Balance sheet

See full
Cash & equivalents$13.1M+489%
Total debt$18.1M-27.5%
Total equity$175.8M+4.2%
Total assets$227.6M+2.5%

Cash flow

See full
Operating cash flow$6.1M+62.0%
CapEx$848.0K+56.2%
Free cash flow$5.3M+63.0%

Valuation

See full
Market cap$259.26M+34.8%
Enterprise value$264.28M+28.7%
P/E16.8×+1.8×
P/S1.1×+0.3×

Profitability

See full
Gross margin27.9%+2.8pp
Operating margin8.7%+0.4pp
Net margin6.4%+0.9pp
FCF margin13.2%-1.8pp

Returns & leverage

See full
Return on equity9%+0.7pp
Debt / equity0.1×0.0×
Current ratio3.1×-1.0×

Where this comes from

Reported directly by Escalade in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Escalade’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Escalade's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Escalade's SG&A?
Escalade (ESCA) reported SG&A of $10.73M in Q1 2026.
How has Escalade's SG&A changed year-over-year?
Escalade's SG&A increased by 1.5% year-over-year, from $10.57M to $10.73M.
What is the long-term trend for Escalade's SG&A?
Over 3 years (2022 to 2025), Escalade's SG&A has grown at a -0.9% compound annual growth rate (CAGR), from $44.77M to $43.63M.
What does SG&A mean?
Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.